XML 74 R57.htm IDEA: XBRL DOCUMENT v3.19.1
Equity Financing - Additional Information (Detail) - USD ($)
1 Months Ended 12 Months Ended
Aug. 17, 2018
Aug. 14, 2018
Feb. 28, 2018
Oct. 31, 2017
Jan. 31, 2017
Sep. 30, 2016
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Jan. 31, 2019
Apr. 19, 2018
Apr. 30, 2017
Subsidiary Sale Of Stock [Line Items]                        
Proceed from private placement and equity issuances, gross         $ 26,100,000 $ 13,800,000            
Preferred stock conversion rate                     100.00%  
2016 Placement Warrants                        
Subsidiary Sale Of Stock [Line Items]                        
Warrants to purchase common stock, shares           1,380,745            
Warrant exercise price           $ 2.95 $ 2.95          
Warrant expiration period           7 years 7 years          
2017 Placement Warrants                        
Subsidiary Sale Of Stock [Line Items]                        
Warrants to purchase common stock, shares         1,720,512              
Warrant exercise price         $ 3.17   $ 3.17          
Warrant expiration date         Jan. 31, 2024              
Warrant expiration period             7 years          
Warrant exercisable date         Jul. 31, 2017              
Underwriters | Common Stock                        
Subsidiary Sale Of Stock [Line Items]                        
Underwriting agreement date   Aug. 14, 2018                    
Number of shares issued in transaction   16,216,217                    
Sale of stock, price   $ 9.25                    
Option to purchase additional shares   30 days                    
Aggregate proceeds from issuance of common stock $ 161,900,000                      
Underwriters | Common Stock | Maximum                        
Subsidiary Sale Of Stock [Line Items]                        
Number of additional shares issued in transaction   2,432,432                    
2017 Direct Registered Offering | Common Stock                        
Subsidiary Sale Of Stock [Line Items]                        
Aggregate proceeds from issuance of common stock       $ 49,900,000                
Stock issued during period       8,382,643                
March 2018 Direct Registered Offering                        
Subsidiary Sale Of Stock [Line Items]                        
Proceed from private placement and equity issuances, gross     $ 59,100,000                  
March 2018 Direct Registered Offering | Common Stock                        
Subsidiary Sale Of Stock [Line Items]                        
Stock issued during period     4,090,000                  
March 2018 Direct Registered Offering | Series A Convertible Preferred Stock                        
Subsidiary Sale Of Stock [Line Items]                        
Stock issued during period     3,000,581                  
March 2018 Direct Registered Offering Warrants                        
Subsidiary Sale Of Stock [Line Items]                        
Warrants to purchase common stock, shares     1,418,116                  
Warrant exercise price     $ 8.31                  
Warrant expiration date     Mar. 31, 2025                  
2016 Private Placement | Common Stock                        
Subsidiary Sale Of Stock [Line Items]                        
Number of shares issued in transaction           4,602,506            
Proceed from private placement and equity issuances, gross           $ 13,800,000            
2017 Private Placement | Common Stock                        
Subsidiary Sale Of Stock [Line Items]                        
Number of shares issued in transaction         8,602,589              
Proceed from private placement and equity issuances, gross         $ 26,100,000              
At The Market Offering Program                        
Subsidiary Sale Of Stock [Line Items]                        
Aggregate proceeds from issuance of common stock             $ 278,000 $ 40,126,000 $ 0      
At The Market Offering Program | Maximum                        
Subsidiary Sale Of Stock [Line Items]                        
Maximum aggregate offering price         $ 75,000,000              
Maximum common stock saleable shares, value                       $ 50,000,000
At The Market Offering Program | Maximum | Subsequent Event                        
Subsidiary Sale Of Stock [Line Items]                        
Maximum aggregate offering price                   $ 250,000,000    
Maximum common stock saleable shares, value                   $ 100,000,000    
At The Market Offering Program | Common Stock                        
Subsidiary Sale Of Stock [Line Items]                        
Aggregate proceeds from issuance of common stock             $ 300,000 $ 40,100,000        
Stock issued during period             33,097 6,575,062        
Average market price per share             $ 8.41 $ 6.10